Search

Search Funnelback University

Search powered by Funnelback
Your query has been expanded to `news stories` |u:www.enterprize.cam.ac.uk.  Search for `news stories` |u:www.enterprise.cam.ac.uk instead.
31 - 80 of 178 search results for `news stories` |u:www.enterprise.cam.ac.uk or `news stories` |u:www.enterprize.cam.ac.uk
  1. Fully-matching results

  2. KARPAS 25 Human Myeloma cell line

    https://www.enterprise.cam.ac.uk/reagents/karpas-25-human-myeloma-cell-line/
    Thumbnail for KARPAS 25 Human Myeloma cell line 9 May 2022: KARPAS 25 Human Myeloma cell line useful in oncology research, developed at the University of Cambridge.
  3. Impact Insight video case study: Xampla – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/case-studies/impact-insight-video-case-study-xampla/
    Thumbnail for Impact Insight video case study: Xampla – Cambridge Enterprise 15 Mar 2022: The first in our new series of Impact Insight videos focuses on the exciting research commercialisation story behind Xampla.
  4. Research tools licensing – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/for-the-university/develop-a-commercial-opportunity/research-tools/
    19 Dec 2022: We have been licensing research tools for over a decade and can therefore fully support you through the process.
  5. Impact Insight: Versed AI – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/video/impact-insight-versed-ai/
    Thumbnail for Impact Insight: Versed AI – Cambridge Enterprise 12 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Impact Insight: Versed AI. Share:. Impact Insight video case study: Versed AI. The second in our Impact Insight video series focuses on Versed AI. It tells the story behind the creation
  6. KARPAS 417 Human Myeloma cell line

    https://www.enterprise.cam.ac.uk/reagents/karpas-417-human-myeloma-cell-line/
    Thumbnail for KARPAS 417 Human Myeloma cell line 9 May 2022: KARPAS 417 Human Myeloma cell line useful in oncology research, developed at the University of Cambridge.
  7. TenU receives £4 million to boost research commercialisation –…

    https://www.enterprise.cam.ac.uk/news/tenu-receives-4-million-to-boost-research-commercialisation/
    Thumbnail for TenU receives £4 million to boost research commercialisation – Cambridge Enterprise 18 Aug 2022: International research commercialisation collaboration TenU receives £4m funding boost
  8. Impact Insight video case study: iKVA – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/case-studies/impact-insight-video-case-study-ikva/
    Thumbnail for Impact Insight video case study: iKVA – Cambridge Enterprise 23 Mar 2022: The story behind the creation of iKVA, a University of Cambridge spin-out that uses AI to facilitate knowledge management for multinationals.
  9. Impact Insight: Kalamna CIC – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/video/impact-insight-kalamna-cic/
    Thumbnail for Impact Insight: Kalamna CIC – Cambridge Enterprise 12 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Impact Insight: Kalamna CIC. Share:. Impact Insight video case study: Kalamna toolkit. The third in our Impact Insight video series focuses on the licensing of the Kalamna toolkit for
  10. KARPAS 929 Human Myeloma cell line - Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/reagents/karpas-929-human-myeloma-cell-line/
    Thumbnail for KARPAS 929 Human Myeloma cell line - Cambridge Enterprise 9 May 2022: KARPAS 929 Human Myeloma cell line, developed at the University of Cambridge, useful in oncology research.
  11. £1.5m seed funding for Cambridge spin-out iKVA – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/news/university-of-cambridge-spin-out-ikva-secures-1-5m-seed-funding/
    Thumbnail for £1.5m seed funding for Cambridge spin-out iKVA – Cambridge Enterprise 2 Feb 2022: University of Cambridge spin-out iKVA has secured £1.5m in seed funding to begin the rollout of its unique AI technology.
  12. Realising the market potential of software – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/for-the-university/develop-a-commercial-opportunity/realising-the-market-potential-of-software/
    18 Jul 2022: Related news and case studies. Pause. Play. Review our answers to your most frequently asked questions.
  13. Impact Insight video case study: Versed AI – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/case-studies/impact-insight-video-case-study-versed-ai/
    Thumbnail for Impact Insight video case study: Versed AI – Cambridge Enterprise 15 Mar 2022: The second in our new series of Impact Insight videos focuses on the exciting research commercialisation story behind Versed AI.
  14. Watch our #nextgreatidea film – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/video/watch-our-nextgreatidea-film/
    Thumbnail for Watch our #nextgreatidea film – Cambridge Enterprise 15 Feb 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Watch our #nextgreatidea film. Share:. Our film is a distinctive take on innovation that showcases some of the world-changing ideas we have supported in the journey to market – from a
  15. KARPAS 707H Human Myeloma cell line

    https://www.enterprise.cam.ac.uk/reagents/karpas-707h-human-myeloma-cell-line/
    Thumbnail for KARPAS 707H Human Myeloma cell line 9 May 2022: KARPAS 707H Human myeloma cell line suitable for the generation of stable human hybridomas for the creation of fully human monoclonal antibodies.
  16. Finalists announced in 2022 Chris Abell Postdoc Business Plan…

    https://www.enterprise.cam.ac.uk/news/finalists-announced-in-2022-chris-abell-postdoc-business-plan-competition/
    Thumbnail for Finalists announced in 2022 Chris Abell Postdoc Business Plan Competition – Cambridge Enterprise 4 Oct 2022: Six finalists announced for the 2022 Chris Abell Postdoc Business Plan Competition.
  17. Ceres Agri-Tech Partnership – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/case-studies/ceres-a-rich-harvest-of-agri-tech-projects/
    Thumbnail for Ceres Agri-Tech Partnership – Cambridge Enterprise 11 Apr 2022: This initiative links the Universities of Cambridge, Lincoln, Reading, Hertfordshire, and East Anglia to drive commercialisation of agri-tech research and innovation.
  18. Creative Cambridge 2022 highlights – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/video/creative-cambridge-2022-highlights/
    Thumbnail for Creative Cambridge 2022 highlights – Cambridge Enterprise 18 Aug 2022: More on Creative Cambridge. Discover Creative Cambridge. Learn more about our Creative Cambridge initiative, sign up to our dedicated newsletter to keep informed about forthcoming events and news for the creative
  19. KARPAS 1272 Human Myeloma cell line

    https://www.enterprise.cam.ac.uk/reagents/karpas-1272-human-myeloma-cell-line/
    Thumbnail for KARPAS 1272 Human Myeloma cell line 9 May 2022: KARPAS 1272 Human Myeloma cell line, useful in oncology research, developed at the University of Cambridge.
  20. The journey of a University idea – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/for-the-university/develop-a-commercial-opportunity/the-journey-of-a-university-idea/
    10 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. The journey of a University idea. How to make your commercial idea thrive. You have come up with an exciting commercial idea – but what do you do next? The diagram below gives an
  21. Semi-finalists announced in 2022 Chris Abell Postdoc Business Plan…

    https://www.enterprise.cam.ac.uk/news/semi-finalists-announced-in-2022-chris-abell-postdoc-business-plan-competition/
    Thumbnail for Semi-finalists announced in 2022 Chris Abell Postdoc Business Plan Competition – Cambridge Enterprise 17 Aug 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 28 July 2022. Semi-finalists announced in 2022 Chris Abell Postdoc Business Plan Competition. Share:. This year’s Chris Abell Postdoc Business Plan Competition is sponsored byand
  22. Nyobolt: Supercharging the electric revolution – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/case-studies/nyobolt-supercharging-the-electric-revolution/
    Thumbnail for Nyobolt: Supercharging the electric revolution – Cambridge Enterprise 11 Apr 2022: Nyobolt is a University spin out from the Yusuf Hamied Department of Chemistry, commercialising a novel ultra-high power battery technology
  23. KARPAS 241 Human Monoblastic cell line

    https://www.enterprise.cam.ac.uk/reagents/karpas-241-human-monoblastic-cell-line/
    Thumbnail for KARPAS 241 Human Monoblastic cell line 9 May 2022: KARPAS 241 Human Monoblastic cell line useful in oncology research, developed at the University of Cambridge.
  24. Sustainability, investment and the Carbon Challenge – Cambridge…

    https://www.enterprise.cam.ac.uk/video/sustainability-investment-and-the-carbon-challenge/
    Thumbnail for Sustainability, investment and the Carbon Challenge – Cambridge Enterprise 12 Oct 2022: Chris Gibbs shares his perspectives on the importance of sustainability, investing in sustainability businesses and building entrepreneurial mindsets through the Carbon Challenge.
  25. Sparxell wins the 2022 Chris Abell Postdoc Business Plan Competition…

    https://www.enterprise.cam.ac.uk/news/sparxell-wins-the-2022-chris-abell-postdoc-business-plan-competition/
    Thumbnail for Sparxell wins the 2022 Chris Abell Postdoc Business Plan Competition – Cambridge Enterprise 11 Nov 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 11 November 2022. Sparxell wins the 2022 Chris Abell Postdoc Business Plan Competition. Share:. Sparxell has won the Chris Abell Postdoc Business Plan Competition 2022, securing the £20
  26. Impact Insight video case study: Kalamna toolkit – Cambridge…

    https://www.enterprise.cam.ac.uk/case-studies/impact-insight-video-case-study-kalamna-toolkit/
    Thumbnail for Impact Insight video case study: Kalamna toolkit – Cambridge Enterprise 15 Mar 2022: Kalamna, a University of Cambridge social enterprise, has developed an innovative phonics-based toolkit for learning Arabic.
  27. CAM2 software for hearing aid fitting – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/reagents/cam2-software-for-hearing-aid-fitting/
    Thumbnail for CAM2 software for hearing aid fitting – Cambridge Enterprise 9 May 2022: CAM2 software is a package that enables hearing aids to be tailored to an individual’s needs, resulting in improved hearing quality.
  28. Cambridge joins $72.5m round launching mitochondrial therapies…

    https://www.enterprise.cam.ac.uk/news/cambridge-joins-72-5m-round-launching-mitochondrial-therapies-pioneer-pretzel/
    Thumbnail for Cambridge joins $72.5m round launching mitochondrial therapies pioneer Pretzel – Cambridge Enterprise 19 Sep 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 12 September 2022. Cambridge joins $72.5m round launching mitochondrial therapies pioneer Pretzel. Share:. a biotechnology company harnessing the intricacies of mitochondrial biology to
  29. Case study: Futures We Want – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/case-studies/consultancy-services-determining-the-futures-we-want/
    Thumbnail for Case study: Futures We Want – Cambridge Enterprise 11 Apr 2022: Evidence included scientific papers, government reports, and local news articles. The close collaboration with local expert teams throughout the process brought great depth of knowledge, and ensured that visions remained focused
  30. Human CD59 monoclonal antibody YTH 53.1

    https://www.enterprise.cam.ac.uk/reagents/human-cd59-monoclonal-antibody-yth-53-1/
    Thumbnail for Human CD59 monoclonal antibody YTH 53.1 9 May 2022: Hybridoma cell line producing YTH 53.1 antibodies raised against human CD59 which are rat monoclonal antibodies of the IgG2b isotype.
  31. Human CD7 monoclonal antibody YTH 30.15

    https://www.enterprise.cam.ac.uk/reagents/human-cd7-monoclonal-antibody-yth-30-15/
    Thumbnail for Human CD7 monoclonal antibody YTH 30.15 9 May 2022: Hybridoma cell line producing YTH 30.15 antibodies raised against human CD7 which are rat monoclonal antibodies of the IgG2b isotype.
  32. BOADICEA: Calculating the risk of breast cancer – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/case-studies/boadicea-calculating-the-risk-of-breast-cancer/
    Thumbnail for BOADICEA: Calculating the risk of breast cancer – Cambridge Enterprise 11 Apr 2022: BOADICEA is a platform developed by researchers at the Department of Public Health and Primary Care that calculates the risk of breast cancer.
  33. New grafting technique published in Nature - Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/news/research-supported-by-cambridge-enterprise-and-ceres-agri-tech-published-in-nature/
    Thumbnail for New grafting technique published in Nature - Cambridge Enterprise 16 Mar 2022: New grafting techniqe supported by Cambridge Enterprise and Ceres Agri-Tech could combat Cavendish banana disease
  34. COBRAS Concrete Bridge Assessment Program – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/reagents/cobras-concrete-bridge-assessment-program/
    Thumbnail for COBRAS Concrete Bridge Assessment Program – Cambridge Enterprise 9 May 2022: COBRAS Concrete Bridge Assessment Program is a yield-line analysis software for assessing the ultimate load capacity of concrete structures.
  35. HappyShield: A simple, elegant solution to PPE scarcity – Cambridge…

    https://www.enterprise.cam.ac.uk/case-studies/happyshield-a-simple-elegant-solution-to-ppe-scarcity/
    Thumbnail for HappyShield: A simple, elegant solution to PPE scarcity – Cambridge Enterprise 11 Apr 2022: HappyShield provides a barrier from splashes and sprays of infected bodily fluids and can be cleaned and reused indefinitely.
  36. Cambridge Enterprise leads £1m investment in cancer care management…

    https://www.enterprise.cam.ac.uk/news/cambridge-enterprise-leads-1m-investment-in-cancer-care-management-device-start-up/
    Thumbnail for Cambridge Enterprise leads £1m investment in cancer care management device start-up – Cambridge Enterprise 28 Apr 2022: Cambridge Enterprise leads £1 million investment in 52 North Health, a UK and US-based med-tech start-up.
  37. Rat CD45 monoclonal antibody YTH 24.5

    https://www.enterprise.cam.ac.uk/reagents/human-cd45-monoclonal-antibody-yth-24-5/
    Thumbnail for Rat CD45 monoclonal antibody YTH 24.5 9 May 2022: Hybridoma cell line producing YTH 24.5 antibodies raised against human CD45 which are rat monoclonal antibodies of the IgG2b isotype.
  38. Cambridge Enterprise co-leads £2.4m investment in spin-out developing …

    https://www.enterprise.cam.ac.uk/news/cambridge-enterprise-co-leads-2-4m-investment-in-spin-out-developing-adc-cancer-therapeutics/
    Thumbnail for Cambridge Enterprise co-leads £2.4m investment in spin-out developing ADC cancer therapeutics – Cambridge Enterprise 14 Jun 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 14 June 2022. Cambridge Enterprise co-leads £2.4m investment in spin-out developing ADC cancer therapeutics. Share:. Spirea Limited, a University of Cambridge spin-out company created
  39. Knowledge exchange in southern Africa – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/case-studies/knowledge-exchange-teaching-and-learning-in-southern-africa/
    Thumbnail for Knowledge exchange in southern Africa – Cambridge Enterprise 11 Apr 2022: We ran a knowledge exchange programme on research commercialisation for three southern African universities in 2019.
  40. Human CD11a monoclonal antibody YTH 81.5

    https://www.enterprise.cam.ac.uk/reagents/human-cd11a-monoclonal-antibody-yth-81-5/
    Thumbnail for Human CD11a monoclonal antibody YTH 81.5 9 May 2022: Hybridoma cell line producing YTH 81.5 antibodies raised against human CD11a which are rat monoclonal antibodies of the IgG2a isotype.
  41. Joint Harvard-Cambridge spin-out closes $50m Series A to drive…

    https://www.enterprise.cam.ac.uk/news/joint-harvard-cambridge-spin-out-closes-50m-series-a-to-drive-biomolecular-condensate-drug-discovery/
    Thumbnail for Joint Harvard-Cambridge spin-out closes $50m Series A to drive biomolecular condensate drug discovery – Cambridge Enterprise 4 Jul 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 6 June 2022. Joint Harvard-Cambridge spin-out closes $50m Series A to drive biomolecular condensate drug discovery. Share:. a joint spin-out from the University of Cambridge and Havard
  42. Human CD16 monoclonal antibody YFC 120.5

    https://www.enterprise.cam.ac.uk/reagents/human-cd16-monoclonal-antibody-yfc-120-5/
    Thumbnail for Human CD16 monoclonal antibody YFC 120.5 9 May 2022: Hybridoma cell line producing YFC 120.5 antibodies raised against human CD16 which are rat monoclonal antibodies of the IgG2b isotype.
  43. Cambridge GaN Devices case study – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/case-studies/cambridge-gan-devices-reshaping-power-electronics-for-a-greener-future/
    Thumbnail for Cambridge GaN Devices case study – Cambridge Enterprise 11 Apr 2022: investment. Less than five years later, we again released news about the company. ... This time, however, the news was the completion of a $9.5 million Series A funding round.
  44. Rat CD45 monoclonal antibody YTH 54.12

    https://www.enterprise.cam.ac.uk/reagents/mouse-cd45-monoclonal-antibody-yth-54-12/
    Thumbnail for Rat CD45 monoclonal antibody YTH 54.12 9 May 2022: Hybridoma cell line producing YTH 54.12 antibodies raised against human CD45 which are rat monoclonal antibodies of the IgG2b isotype.
  45. Cambridge spin-out secures $3.4m to invent the way humanity interacts …

    https://www.enterprise.cam.ac.uk/news/cambridge-spin-out-secures-3-4m-to-invent-the-way-humanity-interacts-with-a-i/
    Thumbnail for Cambridge spin-out secures $3.4m to invent the way humanity interacts with AI – Cambridge Enterprise 23 Mar 2022: Tenyks, a University of Cambridge spin-out focused on helping machine learning engineers build better, safer artificial intelligence, has raised a $3.4 million seed round.
  46. Human CD18 monoclonal antibody YFC 118.12

    https://www.enterprise.cam.ac.uk/reagents/human-cd18-monoclonal-antibody-yfc-118-12/
    Thumbnail for Human CD18 monoclonal antibody YFC 118.12 9 May 2022: Hybridoma cell line producing YFC118.12 antibodies raised against human CD18 which are rat monoclonal antibodies of the IgG2b isotype.
  47. Apollo Therapeutics: Pioneering collaboration launches its next phase …

    https://www.enterprise.cam.ac.uk/case-studies/apollo-therapeutics-pioneering-collaboration-launches-its-next-phase/
    Thumbnail for Apollo Therapeutics: Pioneering collaboration launches its next phase – Cambridge Enterprise 11 Apr 2022: Apollo Therapeutics was launched as a £100 million biopharmaceutical company in June 2021.
  48. Cambridge Enterprise licenses unique new device for cancer diagnosis…

    https://www.enterprise.cam.ac.uk/news/cambridge-enterprise-licences-unique-new-device-for-cancer-diagnosis/
    Thumbnail for Cambridge Enterprise licenses unique new device for cancer diagnosis – Cambridge Enterprise 15 Nov 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 1 November 2022. Cambridge Enterprise licenses unique new device for cancer diagnosis. Share:. Transforming the process of prostate cancer diagnosis. This month will see the launch of a
  49. Human CD28 monoclonal antibody YTH 913.12

    https://www.enterprise.cam.ac.uk/reagents/human-cd28-monoclonal-antibody-yth-913-12/
    Thumbnail for Human CD28 monoclonal antibody YTH 913.12 9 May 2022: Hybridoma cell line producing YTH 913.12 antibodies raised against human CD28 which are rat monoclonal antibodies of the IgG2b isotype.
  50. Cambridge Enterprise, Cambridge Innovation Capital, and University…

    https://www.enterprise.cam.ac.uk/news/cambridge-enterprise-cambridge-innovation-capital-and-the-university-of-cambridge-launch-ambitious-innovate-cambridge-initiative/
    Thumbnail for Cambridge Enterprise, Cambridge Innovation Capital, and University launch Innovate Cambridge – Cambridge Enterprise 20 Sep 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 20 September 2022. Cambridge Enterprise, Cambridge Innovation Capital, and University launch Innovate Cambridge. Share:. Cambridge Enterprise, Cambridge Innovation Capital, and the
  51. A consultant's miscellany: Hugh Hunt's many consultancy…

    https://www.enterprise.cam.ac.uk/case-studies/consultants-miscellany-hugh-hunts-many-varied-consultancy-projects/
    Thumbnail for A consultant's miscellany: Hugh Hunt's many consultancy projects – Cambridge Enterprise 22 Mar 2022: When Cambridge Enterprise was looking to make a film about Consultancy Services, Dr Hugh Hunt, Cambridge University Reader in Engineering Dynamics and...

Refine your results

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Recent searches

Your search history is empty.